drugset / Trial / NCT05788991

Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis

NCT05788991

Phase 4 Terminated 151 enrolled Medinova AG
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this clinical trial is to show the efficacy and safety of dequalinium chloride in the treatment of bacterial vaginosis compared to metronidazole.

Timeline

Start
2021-07-26
Primary completion
2022-08-25
Completion
2022-08-25

Drugs

EvaluationDrugModalityDoseRoute
Subject DEQUALINIUM Small molecule 10 mg Other
Comparator Metronidazole Small molecule 500 mg Oral

Indications